David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Freshpet
FRPT
$3.6B
| $4.24M | ﹤0.01% |
26,682
-66,625
| -71% | -$10.1M |
|
1852
CALL
Alnylam Pharmaceuticals
ALNY
$32B
| $4.24M | ﹤0.01% |
30,000
-22,800
| -43% | -$3.43M |
|
|
RRD
1853
DELISTED
RR Donnelley & Sons Co.
RRD
| $4.22M | ﹤0.01% |
1,039,550
+721,805
| +227% | +$2.29M |
|
1854
Global Net Lease
GNL
$2.11B
| $4.21M | ﹤0.01% |
+233,073
| New | +$4.13M |
|
1855
PUT
Xerox
XRX
$391M
| $4.2M | ﹤0.01% |
173,200
-123,200
| -42% | -$2.95M |
|
1856
Fidelity National Financial
FNF
$12.7B
| $4.2M | ﹤0.01% |
107,474
-732,463
| -87% | -$27.8M |
|
1857
Enova International
ENVA
$5.89B
| $4.2M | ﹤0.01% |
118,239
-215,498
| -65% | -$6.45M |
|
1858
Academy Sports + Outdoors
ASO
$2.7B
| $4.19M | ﹤0.01% |
155,320
+32,974
| +27% | +$788K |
|
1859
Blackbaud
BLKB
$2.14B
| $4.19M | ﹤0.01% |
58,935
-30,597
| -34% | -$2.11M |
|
1860
Littelfuse
LFUS
$10.6B
| $4.19M | ﹤0.01% |
15,832
-8,846
| -36% | -$2.36M |
|
1861
Sensient Technologies
SXT
$5.83B
| $4.18M | ﹤0.01% |
53,655
+46,615
| +662% | +$3.58M |
|
1862
CALL
Huazhu Hotels Group
HTHT
$15.1B
| $4.18M | ﹤0.01% |
+76,100
| New | +$4.07M |
|
1863
CALL
Reliance Steel & Aluminium
RS
$20B
| $4.17M | ﹤0.01% |
+27,400
| New | +$3.69M |
|
1864
Lindsay Corp
LNN
$1.16B
| $4.17M | ﹤0.01% |
25,020
-12,444
| -33% | -$1.93M |
|
|
MPT
1865
Medical Properties Trust
MPT
$2.44B
| $4.17M | ﹤0.01% |
195,813
-31,737
| -14% | -$682K |
|
1866
PUT
ON Semiconductor
ON
$28.5B
| $4.16M | ﹤0.01% |
100,000
-71,800
| -42% | -$2.76M |
|
1867
Rogers Communications
RCI
$20B
| $4.16M | ﹤0.01% |
+90,124
| New | +$4.22M |
|
|
ALEX
1868
DELISTED
Alexander & Baldwin
ALEX
| $4.16M | ﹤0.01% |
247,557
-61,053
| -20% | -$1.05M |
|
1869
Magnite
MGNI
$3.35B
| $4.16M | ﹤0.01% |
99,883
+76,738
| +332% | +$3.32M |
|
|
SPR
1870
PUT
DELISTED
Spirit AeroSystems
SPR
| $4.16M | ﹤0.01% |
85,400
+33,000
| +63% | +$1.41M |
|
|
CAI
1871
DELISTED
CAI International, Inc.
CAI
| $4.16M | ﹤0.01% |
91,268
+28,466
| +45% | +$1.12M |
|
|
VYGG
1872
DELISTED
Vy Global Growth
VYGG
| $4.15M | ﹤0.01% |
410,413
-72,962
| -15% | -$807K |
|
1873
American Public Education
APEI
$842M
| $4.14M | ﹤0.01% |
116,249
-38,551
| -25% | -$1.21M |
|
1874
Advanced Energy
AEIS
$11.3B
| $4.14M | ﹤0.01% |
37,924
-47,702
| -56% | -$5.17M |
|
1875
United Parcel Service
UPS
$89.9B
| $4.12M | ﹤0.01% |
24,227
+6,280
| +35% | +$1.02M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.